Dx & Vx Co., Ltd. (KOSDAQ:180400)
South Korea · Delayed Price · Currency is KRW 2,365.00
+25.00 (1.07%)
At close: Oct 2, 2026
Dx & Vx Market Cap
Dx & Vx has a market cap or net worth of 232.78 billion as of October 2, 2026. Its market cap has increased by 120.49% in one year.
Market Cap
232.78B
Enterprise Value
198.95B
Revenue
26.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,365.00
ChartMarket Cap Chart
Since November 20, 2015, Dx & Vx's market cap has increased from 75.32B to 232.78B, an increase of 209.08%. That is a compound annual growth rate of 10.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 232.78B | 50.62% |
| Dec 30, 2025 | 154.55B | 68.91% |
| Dec 30, 2024 | 91.50B | -48.77% |
| Dec 28, 2023 | 178.59B | 52.96% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 192.21B |
| GENINUS | 82.33B |
| GC Medical Science | 79.68B |
| Inventera | 76.77B |
| Protia | 76.38B |
| Cytogen | 74.24B |
| HLB Panagene | 56.00B |
| Seoulin Bioscience | 36.40B |